Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma × olaratumab × Clear all

Phase

Status

Completed 6 Unknown 1 Terminated 1 Approved for marketing 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Doxorubicin 14 Radiotherapy 9 Ifosfamide 9 apatinib 8 Cyclophosphamide 8 anlotinib 7 Vincristine 5 Dactinomycin 5 camrelizumab 4 toripalimab 3 Trabectedin 3 Radiation Dose Hypofractionation 3 Etoposide 3 Docetaxel 3 brostallicin 2 Topotecan 2 Temozolomide 2 Sorafenib 2 Oncolytic Virotherapy 2 Nivolumab 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Ipilimumab 2 Gene Expression Profiling 2 Gemcitabine 2 Drug Therapy 2 Busulfan 2 Amplified Fragment Length Polymorphism Analysis 2 trofosfamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03985722 2023-03-27

OLATRASTS

Grupo Espanol de Investigacion en Sarcomas

Phase 1 Unknown

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡